An announcement on the deal may arrive in the next month or, at the latest, by the end of September, SVB Leerink analyst Ana Gupte told Business Insider. While Dealreporter first said in April that Anthem was a top contender in the sale, Ms. Grupte said Anthem’s recent acquisition of behavioral health provider Beacon Health Options likely takes the insurer out of the running.
Ms. Gupte anticipates that Magellan will be acquired for roughly $85 to $90 a share. As of June 10, Magellan had a market value of $1.6 billion, according to the report.
Read more here.
More articles on payers:
Anthem to cover some WellStar services, state order says
Q&A: Allina Health | Aetna CEO on the joint venture’s first year
UPMC backpedals on controversial prepayment policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
